Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.070 CHF
−308.39 M CHF
663.15 M CHF
145.72 M
About Ionis Pharmaceuticals, Inc.
Sector
CEO
Brett P. Monia
Headquarters
Carlsbad
Website
Founded
1989
FIGI
BBG007FJP026
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
IONS5397611
Ionis Pharmaceuticals, Inc. 0.0% 01-APR-2026Yield to maturity
3.35%
Maturity date
Apr 1, 2026
IONS5835891
Ionis Pharmaceuticals, Inc. 1.75% 15-JUN-2028Yield to maturity
1.73%
Maturity date
Jun 15, 2028
IONS5104819
Ionis Pharmaceuticals, Inc. 0.125% 15-DEC-2024Yield to maturity
1.23%
Maturity date
Dec 15, 2024
Explore more bonds
Frequently Asked Questions
The current price of ISI is 37.059 CHF — it has decreased by −8.04% in the past 24 hours. Watch IONIS PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange IONIS PHARMACEUTICALS INC stocks are traded under the ticker ISI.
ISI stock hasn't changed in a week, the last month showed zero change in price, over the last year IONIS PHARMACEUTICALS INC has showed a −3.45% decrease.
We've gathered analysts' opinions on IONIS PHARMACEUTICALS INC future price: according to them, ISI price has a max estimate of 67.91 CHF and a min estimate of 32.63 CHF. Watch ISI chart and read a more detailed IONIS PHARMACEUTICALS INC stock forecast: see what analysts think of IONIS PHARMACEUTICALS INC and suggest that you do with its stocks.
ISI stock is 8.75% volatile and has beta coefficient of 0.27. Track IONIS PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is IONIS PHARMACEUTICALS INC there?
Today IONIS PHARMACEUTICALS INC has the market capitalization of 5.24 B, it has decreased by −3.62% over the last week.
Yes, you can track IONIS PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
IONIS PHARMACEUTICALS INC is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
ISI earnings for the last quarter are −0.81 CHF per share, whereas the estimation was −0.95 CHF resulting in a 15.61% surprise. The estimated earnings for the next quarter are −0.98 CHF per share. See more details about IONIS PHARMACEUTICALS INC earnings.
IONIS PHARMACEUTICALS INC revenue for the last quarter amounts to 113.56 M CHF, despite the estimated figure of 109.80 M CHF. In the next quarter, revenue is expected to reach 125.56 M CHF.
ISI net income for the last quarter is −119.05 M CHF, while the quarter before that showed −59.57 M CHF of net income which accounts for −99.83% change. Track more IONIS PHARMACEUTICALS INC financial stats to get the full picture.
No, ISI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 16, 2024, the company has 927.00 employees. See our rating of the largest employees — is IONIS PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IONIS PHARMACEUTICALS INC EBITDA is −294.84 M CHF, and current EBITDA margin is −42.05%. See more stats in IONIS PHARMACEUTICALS INC financial statements.
Like other stocks, ISI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IONIS PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.